Project Code: 10457954
Faculty: Liggins Institute
Department: Liggins Institute
Main Supervisor: Professor Caroline Crowther
Application open date: 01 Nov 2019
Application deadline: 30 Jun 2021
Enrolment information: NZ Citizens, NZ Permanent Residents, International
Diabetes that develops during pregnancy or gestational diabetes (GDM) is a significant health problem that has a major, negative impact on maternal and perinatal health with lifelong consequences. GDM is associated with an increased risk of later diabetes in mothers and with obesity and developmental delay in their children. What is not known is how glycaemic targets of GDM management during pregnancy alter these consequences.
This study will undertake the assessment of long-term outcomes for the children recruited to the TARGET Study using data linkage. NZ's unique health data environment provides near complete data coverage for many variables via linkage across national and regional databases.
If tighter targets led to improved outcomes for mothers or children, then this would help break the inter-generational cycle of diabetes and obesity and help stem the epidemic of these problems into the future.
Background in a health discipline and a clinical background. Examples include (but are not limited to) medicine, nursing, paediatrics, obstetrics, midwifery, public health. Knowledge of the New Zealand health care system is required.
To determine in the TARGET Study cohort whether tighter or less tight glycaemic targets alter growth, health and development of the children.
Here is more information about the TARGET trial: https://www.auckland.ac.nz/en/liggins/our-research/research-themes/healthy-mothers-healthy-babies/clinical-trials/complete-clinical-studies/target.html
- The current research of Professor Caroline Crowther
- Do lower thresholds for diagnosis of gestational diabetes have later benefits for mothers and babies?
- Do tighter glycaemic targets for managing gestational diabetes improve long-term outcomes for mothers? A data linkage study
- Cost consequences of different diagnostic strategies and different treatment targets for women with gestational diabetes